Speaking to CNBC, the Galderma chief explains how Ozempic-style weight loss is feeding spending on Botox and other anti-aging treatments.
Recap by typeshit. Full story at CNBC.
Osbourne says any medicine can be misused and connects Ozempic to the body image struggles he had when he was younger.
A one-line stock move for the maker of Mounjaro and Zepbound, with no reason given for the gain.
29:53
Journalist Scott Carney argues in favor of gray-market peptides. Only the title is available, so watch for his full reasoning and treat any health claims with caution.
The company announced exclusive manufacturing rights across its needle-free peptide products. Terms aren't given here.
Researchers used computer screening and lab tests to find peptides from yak bone collagen leftovers that act on MMP-1, an enzyme tied to skin aging.
Asahi Shimbun reports the arrests tied to prescription-free sales of Mounjaro and similar weight loss drugs riding the diet craze.
Loading…